par Lejeune, Bernard ;Wilkin, Paul
Référence Journal de gynécologie obstétrique et biologie de la reproduction, 6, 8, page (1159-1169)
Publication Publié, 1977
Article révisé par les pairs
Résumé : Lynestrenol, which is a progestogen with weak oestrogenic features, has numerous theoretical advantages in the hormonal treatment of endometrial carcinoma of the body of the uterus when associated with combined radiotherapy and surgery. Initial clinical impressions were confirmed by a study of the histological modifications brought about by lynestrenol in this kind of tumour in which are included some poorly differentiated or undifferentiated cases.